日本語English简体中文 繁體中文

300683 Wuhan Hiteck Biological Pharma Co., Ltd.海特生物Shenzhen Stock Exchange

5 posts

Wuhan Hiteck Biological Pharma Co., Ltd. (300683) at a glance

Code
300683
Company
Wuhan Hiteck Biological Pharma Co., Ltd.
Local name
海特生物
Market
Shenzhen Stock Exchange
Share price
CN¥22.58 -0.65 (-2.80%) Nov 6 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Wuhan Hiteck Biological Pharma Co., Ltd. (300683) Stock Price History

Wuhan Hiteck Biological Pharma Co., Ltd. closed at CN¥22.58 on Nov 6, 2026, −11.6% over 1 month, −31.1% over 1 year.

2026-10-13 取締役会決議 第九届董事会第十一次会议决议公告 / 契約の締結 关于与Visara签署HT006.2.2滴眼液项目授权许可协议的公告2026-10-23 四半期報告 2026年三季度报告 / 変更届 关于会计政策变更的公告CN¥27.25CN¥21.60Oct 8Nov 6
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥27.25Oct 8
1-Month LowCN¥21.60Nov 3
1-Week Change+3.7%vs Oct 30
1-Month Change−11.6%vs Sep 30

If you had invested CN¥10,000 1 month ago, it would be worth CN¥8,286 today (−17.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.3%, while this stock moved −17.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 6 (Fri)CN¥22.58−0.65−2.80%
Nov 5 (Thu)CN¥23.23+0.98+4.40%
Nov 4 (Wed)CN¥22.25+0.65+3.01%
Nov 3 (Tue)CN¥21.60−0.40−1.82%
Nov 2 (Mon)CN¥22.00+0.22+1.01%
Oct 30 (Fri)CN¥21.78−0.14−0.64%
Oct 29 (Thu)CN¥21.92−0.41−1.84%
Oct 28 (Wed)CN¥22.33+0.57+2.62%
Oct 27 (Tue)CN¥21.76−1.17−5.10%
Oct 26 (Mon)CN¥22.93−0.69−2.92%
2026-09-28 新薬・製品の承認 关于注射用埃普奈明获得药物临床试验批准通知书的公告2026-10-13 取締役会決議 第九届董事会第十一次会议决议公告 / 契約の締結 关于与Visara签署HT006.2.2滴眼液项目授权许可协议的公告2026-10-23 四半期報告 2026年三季度报告 / 変更届 关于会计政策变更的公告CN¥30.65CN¥21.60Aug 6Nov 6
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥30.65Aug 11
3-Month LowCN¥21.60Nov 3
1-Month Change−11.6%vs Sep 30
3-Month Change−14.1%vs Aug 6

If you had invested CN¥10,000 3 months ago, it would be worth CN¥8,589 today (−14.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −6.4%, while this stock moved −14.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 6 (Fri)CN¥22.58−0.65−2.80%
Nov 5 (Thu)CN¥23.23+0.98+4.40%
Nov 4 (Wed)CN¥22.25+0.65+3.01%
Nov 3 (Tue)CN¥21.60−0.40−1.82%
Nov 2 (Mon)CN¥22.00+0.22+1.01%
Oct 30 (Fri)CN¥21.78−0.14−0.64%
Oct 29 (Thu)CN¥21.92−0.41−1.84%
Oct 28 (Wed)CN¥22.33+0.57+2.62%
Oct 27 (Tue)CN¥21.76−1.17−5.10%
Oct 26 (Mon)CN¥22.93−0.69−2.92%
2026-09-28 新薬・製品の承認 关于注射用埃普奈明获得药物临床试验批准通知书的公告2026-10-13 取締役会決議 第九届董事会第十一次会议决议公告 / 契約の締結 关于与Visara签署HT006.2.2滴眼液项目授权许可协议的公告2026-10-23 四半期報告 2026年三季度报告 / 変更届 关于会计政策变更的公告CN¥38.43CN¥21.60May 6Nov 6
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥38.43May 12
6-Month LowCN¥21.60Nov 3
3-Month Change−14.1%vs Aug 6
6-Month Change−36.4%vs May 6

If you had invested CN¥10,000 6 months ago, it would be worth CN¥6,359 today (−36.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −12.3%, while this stock moved −36.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥22.58+3.7%
Oct 2026CN¥21.78−14.7%
Sep 2026CN¥25.54−0.4%
Aug 2026CN¥25.63−0.5%
Jul 2026CN¥25.77+3.0%
Jun 2026CN¥25.01−9.1%
May 2026CN¥27.50−22.2%
2026-09-28 新薬・製品の承認 关于注射用埃普奈明获得药物临床试验批准通知书的公告2026-10-13 取締役会決議 第九届董事会第十一次会议决议公告 / 契約の締結 关于与Visara签署HT006.2.2滴眼液项目授权许可协议的公告2026-10-23 四半期報告 2026年三季度报告 / 変更届 关于会计政策变更的公告CN¥48.78CN¥21.60Nov 6Nov 6
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥48.78Apr 1
52-Week LowCN¥21.60Nov 3
Year to Date−18.6%vs Dec 31
From 52-Week High−53.7%Apr 1

If you had invested CN¥10,000 1 year ago, it would be worth CN¥6,895 today (−31.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.9%, while this stock moved −31.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥22.58+3.7%
Oct 2026CN¥21.78−14.7%
Sep 2026CN¥25.54−0.4%
Aug 2026CN¥25.63−0.5%
Jul 2026CN¥25.77+3.0%
Jun 2026CN¥25.01−9.1%
May 2026CN¥27.50−22.2%
Apr 2026CN¥35.34−18.5%
Mar 2026CN¥43.36+29.6%
Feb 2026CN¥33.46+10.4%
Jan 2026CN¥30.31+9.3%
Dec 2025CN¥27.73−9.9%
Nov 2025CN¥30.78−10.7%
CN¥59.56CN¥20.29Nov 6, 2023Nov 6, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥59.56Jul 28, 2025
3-Year LowCN¥20.29Sep 16, 2024
Annualized Return−16.6%
Max Drawdown−63.4%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥5,805 today (−42.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +20.1%, while this stock moved −42.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥22.58−18.6%
2025CN¥27.73―
CN¥69.72CN¥20.29Nov 8, 2021Nov 6, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥69.72Jan 17, 2022
5-Year LowCN¥20.29Sep 16, 2024
Annualized Return−15.1%
Max Drawdown−70.9%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥4,428 today (−55.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +3.1%, while this stock moved −55.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥22.58−18.6%
2025CN¥27.73―
CN¥76.00CN¥20.29Aug 7, 2017Nov 6, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥76.00Mar 2020
All-Time LowCN¥20.29Sep 2024
Total Change−60.4%vs Aug 2017
Annualized Return−9.5%

If you had invested CN¥10,000 in Aug 2017, it would be worth CN¥3,961 today (−60.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +8.6%, while this stock moved −60.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥22.58−18.6%
2025CN¥27.73+22.6%
2024CN¥22.61−37.4%
2023CN¥36.11+2.0%
2022CN¥35.40−40.6%
2021CN¥59.56+45.7%
2020CN¥40.88+34.2%
2019CN¥30.46+13.4%
2018CN¥26.87−50.8%
2017CN¥54.60―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Aug 2017). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.5 Disclosure 2026/10/23 09:00
変更届
关于会计政策变更的公告
Delete
No.4 Disclosure 2026/10/23 09:00
四半期報告
2026年三季度报告
Delete
No.3 Disclosure 2026/10/13 09:00
契約の締結
关于与Visara签署HT006.2.2滴眼液项目授权许可协议的公告
Delete
No.2 Disclosure 2026/10/13 09:00
取締役会決議
第九届董事会第十一次会议决议公告
Delete
No.1 Disclosure 2026/09/28 09:00
新薬・製品の承認
关于注射用埃普奈明获得药物临床试验批准通知书的公告
Delete

Write on the Wuhan Hiteck Biological Pharma Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English